Mariner’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-2,434
Closed -$213K – 3694
2025
Q3
$213K Sell
2,434
-310
-11% -$27.7K ﹤0.01% 3118
2025
Q2
$228K Buy
2,744
+328
+14% +$27.4K ﹤0.01% 2941
2025
Q1
$203K Buy
2,416
+8
+0.3% +$744 ﹤0.01% 2996
2024
Q4
$222K Buy
2,408
+45
+2% +$4.33K ﹤0.01% 2917
2024
Q3
$219K Buy
+2,363
New +$205K ﹤0.01% 2860

Other funds holding LMAT

Mariner's LMAT Position: Q4 2025 in Review

Mariner sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 2,434 shares — an estimated $213K sold.

Mariner first reported a position in LMAT in Q3 2024 and held it in 5 quarters. The position peaked at $228K in Q2 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

  • Mariner reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
  • Mariner sold 2,434 LeMaitre Vascular shares in Q4 2025, an estimated $213K.
  • Mariner first reported a position in LeMaitre Vascular in Q3 2024 and held it in 5 quarters.
  • Mariner's LeMaitre Vascular position peaked at $228K in Q2 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Mariner's 13F filing for Q4 2025, filed 13 Feb 2026.